Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
3.275
0.00 (0.00%)
Mar 4, 2026, 7:00 PM EST - Market open
Cryo-Cell International Revenue
In the fiscal year ending November 30, 2025, Cryo-Cell International had annual revenue of $31.57M, down -1.31%. Cryo-Cell International had revenue of $7.84M in the quarter ending November 30, 2025, a decrease of -2.26%.
Revenue (ttm)
$31.57M
Revenue Growth
-1.31%
P/S Ratio
0.84
Revenue / Employee
$367,050
Employees
86
Market Cap
26.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Nov 30, 2025 | 31.57M | -419.79K | -1.31% |
| Nov 30, 2024 | 31.99M | 642.41K | 2.05% |
| Nov 30, 2023 | 31.34M | 1.01M | 3.32% |
| Nov 30, 2022 | 30.34M | 1.45M | 5.03% |
| Nov 30, 2021 | 28.88M | -2.26M | -7.26% |
| Nov 30, 2020 | Pro | Pro | Pro |
| Nov 30, 2019 | Pro | Pro | Pro |
| Nov 30, 2018 | Pro | Pro | Pro |
| Nov 30, 2017 | Pro | Pro | Pro |
| Nov 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| agilon health | 5.93B |
| P3 Health Partners | 1.44B |
| The Oncology Institute | 461.04M |
| DocGo | 368.09M |
| Park Dental Partners | 244.49M |
| biote | 195.65M |
| AirSculpt Technologies | 157.55M |
| The Joint | 54.18M |
CCEL News
- 6 days ago - Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2025 - Business Wire
- 5 months ago - Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2025 Financial Results - Business Wire
- 7 months ago - Cryo-Cell International, Inc. Provides Dividend Update - Business Wire
- 8 months ago - Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2025 Financial Results - Business Wire
- 10 months ago - Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend - Business Wire
- 1 year ago - Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2024 - Business Wire
- 1 year ago - Cord Blood Banking Leader Cryo-Cell Announces Regular Quarterly Cash Dividend and Pause of Strategic Initiatives - Business Wire
- 1 year ago - Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend - Business Wire